The company has received approval from the US Food and Drug Administration (USFDA) for its manufacturing facility located at Kandivalasa village in Vizianagaram district of Andhra Pradesh, SMS Pharmaceuticals said in a regulatory filing.

SMS Pharmaceuticals is engaged in manufacturing of active pharmaceutical ingredients (API) and currently has four production facilities and two research centers in operation.

The company's shares today closed at Rs 123, 1.01 percent down on BSE.

Latest News  from Business News Desk